NCT05889026

The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity: Preliminary Study, Randomized Controlled Trials

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Korea University Guro Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

There are few studies on whether botulinum toxin treatment and extracorporeal shock wave therapy are more effective than botulinum toxin alone treatment for post-stroke spasticity.

Detailed description

If the study results can be drawn that the group receiving extracorporeal shock wave therapy along with botulinum toxin treatment can increase the effect of botulinum toxin treatment and lengthen the treatment period compared to the group with botulinum toxin treatment only, it can be widely used as an auxiliary treatment for botulinum toxin treatment. This study was carried out with the expectation that it would be possible to provide a basis for this.

Conditions

• Stroke
• Hemiplegia, Spastic
• Muscle Spasticity

Interventions

Type	Name	Description
DEVICE	Extracorporeal shock wave therapy	Stimulation was given to the brachial muscle, 1000 times, 4Hz, and energy flux density was 0.030mJ/mm2.
PROCEDURE	Botulinum toxin treatment	The toxin dose was established for each patient: it ranged between 80 unit and 300 unit.

Timeline

• Start date: 2020-08-06
• Primary completion: 2021-09-08
• Completion: 2021-09-08
• First posted: 2023-06-05
• Last updated: 2023-06-05

Locations

1 site across 1 country: South Korea